ATARA BIOTHERAPEUTICS, INC. Other Current Liabilities
ATARA BIOTHERAPEUTICS, INC. (ATRA) had Other Current Liabilities of $3.46 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-12
- 2026-06-30: Other Liabilities, Current $3.46M.
- 2026-03-31: Other Liabilities, Current $2.94M.
- 2025-12-31: Other Liabilities, Current $2.98M.
- 2025-09-30: Other Liabilities, Current $4.65M.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $3.46M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $2.94M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $2.98M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $4.65M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $7.67M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $24.14M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $20.16M 10-K · filed 2026-03-16 | $20.54M 10-K · filed 2025-03-07 |
| 2024-09-30 | $23.64M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $26.15M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $33.05M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $31.83M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $22.57M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $25.17M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $20.20M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $21.39M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $22.81M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $19.78M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $8.05M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $9.06M 10-K · filed 2023-02-08 | |
| 2021-09-30 | $9.27M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $7.37M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $7.90M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $6.06M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $5.27M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $5.68M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $5.94M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $5.73M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $6.48M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $6.42M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $5.35M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $6.41M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $7.93M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $8.75M 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $4.30M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $3.27M 10-K · filed 2019-02-26 | |
| 2016-12-31 | $744.00K 10-K · filed 2018-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |